LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

News

Sort By
This event was published on 21 July
PSCI Webinar: Dust Hazard Assessment and Controls in the Pharma Industry

PSCI Webinar: Dust Hazard Assessment and Controls in the Pharma Industry

Webinar | 7 Aug 2025 15:00–16:30 Kolkata

Understanding dust hazard, assessment and control measures to enhance people and plant safety. In pharmaceutical manufacturing, dust is not just a housekeeping issue — it is a serious safety concern. Many active pharmaceutical ingredients (APIs) and excipients are combustible when finely powdered. If these dusts accumulate or are dispersed in the air, they can pose a significant explosion hazard with serious risk to life and property. Based on of review of the health & safety findings from 180 PSCI audits in 2023, 22% findings were related to Process safety, including explosion risk.

Dust Hazard Assessment, or DHA, is a systematic approach to identifying and mitigating these risks. This webinar will help you gain a better understanding of dust hazard, assessment, and control measures to protect your people and facility from potentially catastrophic explosions and to meeting regulatory and industry safety standards. The following topics will be covered during the webinar:

  • Key definitions
  • Conditions for fire / explosion
  • Chemical flammability properties
  • Typical Ignition Sources
  • Control of flammable atmospheres
  • Dust Hazard Assessment (DHA)
  • Key safety measures to mitigate dust hazard

Suggested Audience: PSCI Suppliers and PSCI members. HSE, Process Safety, Quality and Operations personnel will benefit from attending this webinar

Speaker: Mr. Jitendra Kumar - CEO, FET Solutions Pvt. Ltd. Jitendra is a B.Tech. in Chemical Engineering from IIT Delhi. He has been working in the field of Process Safety for more than 3 decades. He has provided extensive PSM support to numerous sectors such as Pharmaceuticals, Bulk & Fine Chemicals, Agrochemicals, Oil & Gas (onshore and offshore), Petrochemicals, Fertilizers, Food, Engineering, Metallurgy, Cosmetics and more.

He is an expert in conducting HAZID, HAZOP, QRA, FERA, Radiation & Dispersion, MCA, SIL, LOPA, Vent sizing, Chemical Reaction Hazards, Dust Hazards, Electrostatics, Hazardous Area Classification, F&G mapping, Fire fighting system adequacy and design, RAM and Accident Investigation amongst others.

Type
Webinar
Date
7 Aug 2025 15:00–16:30 Kolkata
Language
English
  • Process Safety
  • Spills & Releases
  • Safety - High Risk Areas
This event was published on 8 July
Registration Open
PSCI India Supplier Conference 2025

PSCI India Supplier Conference 2025

Conference | 24–26 Sep 2025

Join us for the PSCI Annual India Pharma Industry Conference & Exhibition:

We are excited to invite you to join us from 24-26 September in Chandigarh for an PSCI Annual India Conference & Exhibition. This event offers a platform to delve into best practices and emerging trends related to the PSCI Principles. Additionally, it provides excellent opportunities for networking with industry peers.

We are delighted to unveil the theme of this year's conference and exhibitions:

Building Resilient Value Chains through Collaborative Leadership in India

  • Date: 24-26 September 2025
  • Time: 09:30 - 17:00
  • Language: English

Location:

Exhibition: The conference will also feature an exhibition highlighting pharmaceutical best practices and success stories aligned with the PSCI Principles. These exhibitions aim to extend discussions beyond the conference room, fostering impactful collaborations and practical approaches to addressing common industry challenges.

Workshop: This year, we are thrilled to announce a workshop centred around the conference theme. This workshop is designed to delve deeper into the topics and themes of our annual conference, providing an in-depth exploration and fostering meaningful discussions.

Contact Information: For any queries or doubts, please reach out to:

  • Subhash Babu, ISS (+91 9327547484) - First point of contact & event organizer
  • Aditya Shirodkar, Abbott (+91 7030129399) - Secondary contact & PSCI India Team Lead

Additional Information: We request that each organization appoints a maximum of 2 participants (in exceptional cases, 3 participants).

The conference agenda will be shared in due course. We look forward to your participation and to making this event a great success together!

Glimpse of the 2024 conference & exhibition: video link

Type
Conference
Date
24–26 Sep 2025
Language
English

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 20 Sep 2025
If you have a user account, please log in before registering.
This event was published on 27 June
Registration Open
PSCI Decarbonization Summit 2025

PSCI Decarbonization Summit 2025

Conference | 22–23 Oct 2025

Register now to attend the PSCI summit on the critical topic of decarbonization

"PSCI has 85 Member companies across the Pharma, Biotech and Med-Tech sector, representing around $1.2 trillion USD or 70% of global sector revenues. We act as one voice for the industry and have come together to give you – our suppliers – a clear unified message on how we will together accelerate action on decarbonization.

"Join us for the PSCI Decarbonization Summit on October 22nd and 23rd 2025, to hear the message from our Members, understand how to build your capability no matter your maturity and set an achievable roadmap to turn decarbonization plans into action by 2030."

Robert Williams, AstraZeneca, PSCI Chair

A sneak peak of what to expect:

  • A tailored agenda for your maturity: From getting to grips with the basics of calculating greenhouse gas baseline emissions, to embedding climate standards across your value chain and developing a robust Net Zero Roadmap That Meets SBTi Criteria, the PSCI Decarbonization Summit has something for everyone.
  • Peer-to-peer learning: Have an innovative solution to accelerate decarbonization? Day 2 of the Summit gives you the opportunity to share existing solutions with PSCI Members to share best practice and drive decarbonization.

The full agenda will be available soon and this summit will take place virtually.

Please contact us with any questions.

Type
Conference
Date
22–23 Oct 2025
Language
English
Add To Calendar

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 22 Oct 2025
If you have a user account, please log in before registering.
This bulletin was published on 26 June
PSCI Members Named on World's Most Sustainable Companies List 2025

PSCI Members Named on World's Most Sustainable Companies List 2025

Congratulations to the PSCI members named in TIME's 500 most sustainable companies list 2025

Over a dozen pharma & healthcare companies, many of which are PSCI members, have been recognized as the world's most sustainable companies 2025. To track how top global firms across industries are rising to sustainability challenges, TIME and data firm Statista partnered to rank the world’s 500 most sustainable companies based on their public commitment to and progress toward sustainability targets during the calendar year of 2023 (the most recent year for which complete data are available).

Special congratulations to Schneider Electric which was ranked number 1 and gained recognition for the Energize program, a supply chain renewables initiative which is endorsed by the PSCI.

You can see the full list of companies here.

This bulletin was published on 19 June
PSCI Endorses Converge Supplier Initiative to Cut Scope 3 Emissions in Pharma

PSCI Endorses Converge Supplier Initiative to Cut Scope 3 Emissions in Pharma

The PSCI has endorsed My Green Lab's Converge Supplier Initiative, a unique industry collaboration designed to support pharmaceutical suppliers in achieving My Green Lab® Certification.

The Converge Supplier Initiative is a unique industry collaboration designed to support pharmaceutical suppliers—including Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and Contract Development & Manufacturing Organizations (CDMOs)—in achieving My Green Lab® Certification. This certification framework enables suppliers to reduce environmental impact, cut energy and water use, lower costs, and align lab operations with corporate sustainability goals. This endorsement from the PSCI underscores growing momentum across the pharmaceutical industry to reduce supply chain (Scope 3) emissions and foster more sustainable lab operations.

Leading pharmaceutical companies, including AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, GSK, MilliporeSigma, Takeda, and UCB, have not only walked the talk by implementing My Green Lab Certification in their own labs to drive down emissions, but also have joined forces to educate and empower their outsourced research partners through the Converge Supplier Initiative. To date, over 147 supplier organizations have joined the initiative, with 32 already completing pilot certifications.

“The research supply chain represents a significant portion of the pharmaceutical industry’s environmental footprint,” said James Connelly, CEO of My Green Lab. “This endorsement by PSCI reinforces the power of collaborative action and positions the Converge Supplier Initiative as a proven, scalable solution for driving impact reduction on the ground in the labs across the industry.”

PSCI unites pharmaceutical and healthcare companies to advance responsible supply chain practices and drive improved safety, environmental, and social outcomes across the global value chain. Together, PSCI and My Green Lab are aligned in their vision for a more sustainable and collaborative future in science.

“Bristol Myers Squibb is excited to see two important relationships come together with PSCI and Converge. With Converge providing a hands-on, practical approach for suppliers with lab operations to address their footprint through My Green Lab Certification, it dovetails well with PSCI’s drive to see the adoption of sustainable practices in pharmaceutical supply chains. This partnership can accelerate the critical need for pharmaceutical supply chains to reduce their footprint while continuing their missions of delivering for patients,” said Devin Carsdale, Associate Director of Sustainability at Bristol Myers Squibb and PSCI Decarbonization Team Co-Lead.

"We proudly operate 17 labs globally, all of which have achieved My Green Lab Certification," said Bill Sterling, Senior Director of Global Environmental Health and Safety, IQVIA Laboratories. "The My Green Lab program has been instrumental in fostering a culture of sustainability and engaging employees at all sites. It helps support our mission to accelerate innovation for a healthier world and features prominently in our annual sustainability report.”

PSCI’s endorsement also supports the broader United Nations-backed Race to Zero campaign, which calls for 95% of participating organizations’ laboratories globally to achieve My Green Lab Certification at the highest 'Green' Level by 2030, a critical milestone in the path of net-zero emissions in science.

Learn more about My Green Lab Certification here.

This event was published on 16 June
UPDATED: Technical Workshop for Indian-based Suppliers: Process Safety & Industrial Hygiene

UPDATED: Technical Workshop for Indian-based Suppliers: Process Safety & Industrial Hygiene

Conference | 16 Jul 2025 09:00–18:00 Kolkata

Please note the updated topic focus for this workshop is now Process Safety and Industrial Hygiene.

If you have registered for the workshop and are no longer interested or able to attend, please contact us to cancel your registration.

The workshop will focus on the topics of Process Safety and Industrial Hygiene, which have been selected considering the needs of the regional pharma industry in India.

The session is aimed at EHS, Safety and Engineering professionals from Pharma manufacturing industries. There is no registration fee for participating in this event.

Please note that registration for this workshop is limited to 50 participants and the event will take place in-person. No virtual option is available.

We are pleased to be joined by speakers from M/S GVS Cibatech and M/S RECOH EHS who will deliver these sessions.

Agenda

  • 09:00-09:30: Registration & Breakfast
  • 09:30-10:15: Opening including PSCI Introduction
  • 10:15-11:30: Technical Session – 1 (Chemical Reaction hazards – M/s GVS Cibatech)
  • 11:30-11:45: 1st Tea / Coffee break
  • 11:45-13:15: Technical Session – 2 (Chemical Reaction Risk Assessment & Controls – M/S GVS Cibatech)
  • 13:15-14:15: Lunch
  • 14:15-15:30: Technical Session – 3 (Industrial Hygiene Risk Assessment – M/S RECOH EHS)
  • 15:30-15:45: 2nd Tea / Coffee break (Hi-Tea)
  • 15:45-17:30: Technical Session – 4 (Industrial Hygiene Risk Assessment & Controls– M/s RECOH EHS)
  • 17:30-18:00: Vote of thanks
Type
Conference
Date
16 Jul 2025 09:00–18:00 Kolkata
Language
English
This event is in the past
This event was published on 13 June
PSCI Webinar: Strategies for Accurate API Exposure Monitoring

PSCI Webinar: Strategies for Accurate API Exposure Monitoring

Webinar | 5 Aug 2025 14:00–15:00 Amsterdam

Webinar Description:
Over 50% of API and surrogate exposure monitoring results are considered unreliable. Accurate, reproducible, and representative monitoring and analysis of API exposures are essential for protecting worker health and developing effective exposure control strategies. Inaccurate results can lead to significant risks for occupational health and undermine the effectiveness of safety measures.

This webinar will offer practical guidance on sampling strategies and methods to support accurate API exposure assessment, in alignment with PSCI’s principles on health and safety. Drawing on insights from over 5,000 API and surrogate exposure monitoring results, the session will help participants strengthen their industrial hygiene programs with evidence-based best practices and real-world lessons learned.

Speakers:

  • Maharshi Mehta, CIH, CSP, FAIHA: Global Leader at International Safety Systems, Inc. 30+ years of conducting industrial hygiene assessment and training at 200+ pharma industries globally. Recepient of Yant Award from American Industrial Hygiene Association and Lifetime Achievement Award from Board for Global EHS Credentialling for promoting occupational hygiene globally.
  • Ankit Sharma, CIH, LFOH, Associate Director, International Safety Systems, Inc. Conducted industrial hygiene assessments and training at more than 50 pharma sites globally. Ankit and his team collected, interpreted and analysed more than 5000 surrogate and API exposure monitoring results. Provided potent compound control solutions and conducted practical training on potent compounds.
Type
Webinar
Date
5 Aug 2025 14:00–15:00 Amsterdam
Language
English
  • Water Use & Management
This resource was published on 12 June

PSCI Anti-Trust Statement EN CN

Organisational Information

The PSCI Anti-trust Statement in English and Chinese.

  • Updated 1 July 2025.
This bulletin was published on 3 June
The Pharmaceutical Supply Chain Initiative (PSCI) Marking a year of global impact

The Pharmaceutical Supply Chain Initiative (PSCI) Marking a year of global impact

  • Building on more than a decade of collaboration, the PSCI celebrates continued growth in membership, record audit sharing, and sector-wide engagement to strengthen responsible practices across the pharmaceutical and healthcare value chain.

  • The PSCI continues to serve as one voice for the pharmaceutical and healthcare industry, defining, instilling, and driving responsible value chain practices through collaboration, shared tools, and sector-wide engagement.

3 June 2025 –The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2024 Annual Report, celebrating a year of strategic transformation and measurable progress in building responsible supply chains across the pharmaceutical and healthcare sectors.

Now representing over 70% of the industry by revenue, PSCI’s 81 member companies continue to collaborate through a shared commitment to the PSCI Principles for Responsible Supply Chain Management. In 2024, PSCI launched a new three-year strategy focused on deepening impact through its three core workstreams: Audit, Capability Building, and Projects.

Reflecting on the previous year, the 2024 PSCI Annual Report showcases the sector’s progress through the PSCI and its three modes of impact:

More Info…
This resource was published on 22 May

BSI Group

Audit Firm Information

Introduction deck for BSI Group